Previous hepatitis B virus infection is associated with worse disease stage and occult hepatitis B virus infection has low prevalence and pathogenicity in hepatitis C virus-positive patients

Liver International

Volumn 23, Issue 1, 2003, Pages 12-18

  Giannini, Edoardo ^a   Ceppa, Paola ^b   Botta, Federica ^a   Fasoli, Alberto ^a   Romagnoli, Paola ^a   Ansaldi, Filippo ^b   Durando, Paolo ^b   Risso, Domenico ^b   Lantieri, Pasquale B ^b   Icardi, Gian C ^b   Testa, Roberto ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

Chronic hepatitis; Cirrhosis; Hepatitis B virus; Hepatitis C virus; Occult infection

Indexed keywords

BIOLOGICAL MARKER; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA; VIRUS RNA;

ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD ANALYSIS; CHRONIC HEPATITIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FREQUENCY ANALYSIS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PATIENT REFERRAL; POLYMERASE CHAIN REACTION; PREVALENCE; VIRUS PATHOGENESIS; AGED; BLOOD; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; EVALUATION; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES;

EID: 0038546403     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0676.2003.01742.x     Document Type: Article

References (32)

1. Hoofnagle J H. Therapy of viral hepatitis. Digestion 1998; 59: 563-78.
2. Seeff L B. Natural history of hepatitis C. Am J Med 1999; 107: 10S-5S.
3. Chu C M. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol 2000; 15: E25-E30.
4. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando M E, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 1999; 341: 22-6.
5. Kingham J G C. Dissecting out crytogenic liver disease. Gut 2000; 47: 328-9.
6. Berasain C, Betés M, Panizo A, et al. Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology. Gut 2000; 47: 429-35.
7. Chemin I, Zoulim F, Merle P, et al. High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology. J Hepatol 2001; 34: 447-54.
8. Shev S, Dhillon A P, Lindh M, et al. The importance of cofactors in the histologic progression of minimal and mild chronic hepatitis C. Liver 1997; 17: 215-23.
9. de Maria N, Colantoni A, Friedlander L, et al. The impact of previous HBV infection on the course of chronic hepatitis C. Am J Gastroenterol 2000; 95: 3529-36.
10. Kubo S, Nishiguchi S, Hirohashi K, et al. Clinical significance of prior hepatitis B virus infection in patients with hepatitis C virus-related hepatocellular carcinoma. Cancer 1999; 86: 793-8.
11. Zignego A L, Fontana R, Puliti S, et al. Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis. J Med. Virol 1997; 51: 313-8.
12. Fukuda R, Ishimura N, Hamamoto S, et al. Co-infection by serologically-silent hepatitis B virus may contribute to poor interferon response in patients with chronic hepatitis C by down regulation of type-I interferon receptor gene expression in the liver. J Med Virol 2001; 63: 220-7.
13. Villa E, Grottola A, Buttafuoco P, et al. Evidence for hepatitis B virus infection in patients with chronic hepatitis C with and without serological markers of hepatitis B. Dig Dis Sci 1995; 40: 8-13.
14. Fukuda R, Ishimura N, Niigaki M, et al. Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus-associated chronic liver disease: clinical and virological significance. J Med Virol 1999; 58: 201-7.
15. Nirei K, Kaneko M, Moriyama M, Arakawa Y. The clinical features of chronic hepatitis C are not affected by the coexistence of hepatitis B virus DNA in patients negative for hepatitis B surface antigen. Intervirology 2000; 43: 95-101.
16. Sagnelli E, Coppola N, Scolastico C, Mogavero A R, Filippini P, Piccinino F. HCV genotype and 'silent' HBV coinfection: two main risk factors for a more severe liver disease. J Med Virol 2001; 64: 350-5.
17. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-9.
18. Simmonds P. Variability of hepatitis C virus. Hepatology 1995; 21: 570-83.
19. Marusawa H, Osaki Y, Kimura T, et al. High prevalence of anti-hepatitis B virus serological markers in patients with hepatitis C virus related chronic liver disease in Japan. Gut 1999; 45: 284-8.
20. Giannini E, Ceppa P, Botta F, et al. Steatosis and bile duct damage in chronic hepatitis C: distribution and relationships in a group of Northern Italian patients. Liver 1999; 19: 432-7.
21. Giannini E, Botta F, Caglieris S, et al. Chronic liver disease related to hepatitis C virus: age of patients seems to be a determinant of severity independently of viral genotype. Eur J Gastroenterol Hepatol 1999; 11: 553-8.
22. Martinot-Peignoux M, Roudot-Thoraval F, Mendel I, et al. Hepatitis C virus genotypes in France: relationship with epidemiology, pathogenicity and response to interferon therapy. J Viral Hepat 1999; 6: 435-43.
23. Saracco G, Sostegni R, Ghisetti V, et al. Hepatitis C virus genotypes in a non-cirrhotic Italian population with chronic hepatitis C correlation with clinical, virological and histological parameters. Results of a prospective multicentre study. J Viral Hepat 2000; 7: 124-9.
24. Grob P, Jilg W, Bornhak H, et al. Serological pattern 'anti-HBc alone': report on a workshop. J Med Virol 2000; 62: 450-5.
25. Greub G, Frei P C. Presence of low levels of anti-HBs antibody in so-called anti-HBc alone subjects. Liver 2001; 21: 380-3.
26. Rehermann B, Ferrari C, Pasquinelli C, Chisari F V. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 1996; 2: 1104-8.
27. Conjeevaram H S, Lok A S. Occult hepatitis B virus infection: a hidden menace? Hepatology 2001; 34: 204-6.
28. Crovari P. Epidemiology of viral hepatitis in Italy. Vaccine 1995; 13: S26-S30.
29. Scully L J, Sung H, Pennie R, Gill P. Detection of hepatitis B virus DNA in the serum of Canadian hepatitis B surface antigen negative, anti-HBc positive individuals, using the polymerase chain reaction. J Med Virol 1994; 64: 350-5.
30. Bréchot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Bréchot P. Persistent hepatitis B virus: clinically significant or purely occult? Hepatology 2001; 34: 194-203.
31. Gerstenkorn C, Cacciola R, Robertson H, Talbot D. Occult hepatitis B infection in chronic hepatitis C liver disease-implications for liver transplantation. Liver 2000; 20: 425.
32. Raimondo G, Balsano C, Craxì A, et al. Occult hepatitis B virus infection. Dig Liver Dis 2000; 32: 822-6.